Conference Description

September 8-9, 2007
Doubletree Chicago-Arlington Heights
75 West Algonquin Road
Arlington Heights, IL 60005
847-364-7600

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated these conferences

CME Credits: 10.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:

This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis. This program will incorporate didactic lectures, case based learning, and utilize an audience response system to facilitate discussion among participants to enhance the educational opportunity.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. review early pathogenesis and prevention of type 2 diabetes, more effectively attain tight glucose control and discuss recent outcomes trials on the development and progression of atherosclerosis in diabetes
2. recognize when to begin basal or pre-mixed insulin and when to progress to basal-bolus insulin, with increased awareness of common pitfalls encountered in initiating and/or maintaining insulin therapy
3. review the latest evidence behind lipid lowering for primary and secondary prevention of cardiovascular disease and recognize important factors in special populations like Metabolic Syndrome, Diabetes, Percutaneous Coronary Intervention, and Acute Coronary Syndrome
4. critically evaluate the evidence behind diagnostic and therapeutic options for constipation predominant irritable bowel syndrome and chronic constipation
5. understand the role of immune response modifiers in the treatment of warts; appreciate the mechanisms of action and efficacy of anti-inflammatory dose doxycycline in acne rosacea, and learn appropriate use of topical steroids and calcipotriene for the treatment of psoriasis
6. recognize the underlying pathophysiology of BPH, utilize the AUA scoring system and choose appropriate pharmacotherapy and surgical interventions for BPH
7. identify the most pertinent adverse events seen in the Women’s Health Initiative and advise patients on the risks and benefits of traditional, non-traditional, and alternative medical interventions for addressing menopausal symptoms
8. more quickly and effectively recognize and diagnose cognitively impaired patients with increased understanding of the pathology of dementia and evolving treatment strategies
9. outline an evidence based approach to the evaluation of insomnia and understand behavioral and pharmacological treatment approaches including their application in the clinical setting
10. utilize diagnostic criteria for Restless Leg Syndrome, understand recent advances in the pathophysiology of the disease, utilize current behavioral and pharmacologic treatment options to reduce symptoms and increase quality of life

Agenda:
Saturday, September 8, 2007

7:15-7:50 am		Registration, Continental Breakfast and Welcome
7:50-8:10		Welcome Remarks and Pre-Assessment Gregg Sherman, MD
8:10-9:10		Fundamentals of Quality Diabetes Care Charles Burant, MD, PhD
9:10-10:10		Demystifying Insulin Therapy: Simple Strategies to Facilitate Initiation and Compliance with Insulin Therapy Kathleen Wyne, MD, PhD
10:10-10:30		Break
10:30-11:30		Lipid Lowering Therapy: Why Lower is Better Martin Zenni, MD
11:30-12:30		Evolving Concepts in GI Motility Disorders: IBS-Constipation and Chronic Constipation Kenneth Devault, MD
12:30-1:30		Lunch
1:30-2:30		Dermatology Therapy Update: Warts, Rosacea and Psoriasis Brian Berman, MD, PhD
2:30-3:30		Science of Sleep: Implications for Insomnia Phyllis Zee, MD
3:30-3:50		Break
3:50-4:50		Restless Legs, Restless Nights Phyllis Zee, MD

Sunday, September 9, 2007

Faculty:
Brian Berman, MD, PhD
Professor of Dermatology and Internal Medicine
The University of Miami School of Medicine
Miami, FL

Charles Burant, MD, PhD
Professor of Internal Medicine and Molecular and Integrative Physiology
University of Michigan
Ann Arbor, MI

Kenneth R. DeVault, MD
Professor of Medicine
Chair, Division of Gastroenterology and Hepatology
Mayo Clinic College of Medicine
Jacksonville, FL

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida
Gainesville, FL

Walter C. Martinez, MD, FAAN
Director, Memory Disorder Center
Director, Premiere Research Institute
Associate Clinical Professor of Neurology at Nova Southeastern University
West Palm Beach, FL

Kathleen L. Wyne, MD, PhD, FACE
Assistant Professor, Division of Endocrinology and Metabolism,
Co-Director, Diabetes Management Program
St. Paul University Hospital
University of Texas Southwestern Medical Center
Dallas, TX

Phyllis C. Zee, MD, PhD
Professor of Neurology and Neurobiolog & Physiology
Northwestern University
Chicago, IL

Martin M. Zenni II, MD, FACC, FSCAI
Associate Professor of Medicine
The University of Florida Health Science Center
Shands Jacksonville
Jacksonville, FL

Program Chair: Gregg Sherman, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 10 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this educational activity for a maximum of 10 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 10 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Amylin, AstraZeneca, Bayer, Boehringer- Ingelheim, Collagenex, Eisai, Merck, NovoNordisk, Sanofi Aventis, Takeda Pharmaceuticals North America, Wyeth.